Elenbecestat(E2609)
|
|
- CAS号:
- 1388651-30-6
- 英文名:
- Elenbecestat(E2609)
- 英文别名:
- Elenbecestat(E26090;Elenbecestat(E2609);Alzheimer's disease,inhibit,Beta-secretase,E-2609,Inhibitor,Elenbecestat,E 2609,β-Secretase,BACE-1,BACE;N-(3-((4aS,5R,7aS)-2-amino-5-methyl-4a,5-dihydro-4H-furo[3,4-d][1,3]thiazin-7a(7H)-yl)-4-fluorophenyl)-5-(difluoromethyl)pyrazine-2-carboxamide;2-Pyrazinecarboxamide, N-[3-[(4aS,5R,7aS)-2-amino-5,7-dihydro-5-methyl-4H-furo[3,4-d][1,3]thiazin-7a(4aH)-yl]-4-fluorophenyl]-5-(difluoromethyl)-
- 中文名:
- Elenbecestat(E2609)
- 中文别名:
- 化合物ELENBECESTAT;E2609 ; E-2609 ; E 2609 ; ELENBECESTAT
- CBNumber:
- CB04868677
- 分子式:
- C19H18F3N5O2S
- 分子量:
- 437.44
- MOL File:
- 1388651-30-6.mol
|
|
|
Elenbecestat(E2609)化学性质
-
密度:
-
1.61±0.1 g/cm3(Predicted)
-
|
-
储存条件:
-
Store at -20°C
-
|
-
溶解度:
-
DMSO : ≥ 250 mg/mL (571.51 mM)
-
|
-
酸度系数(pKa):
-
9.06±0.70(Predicted)
-
|
-
形态:
-
Solid
-
|
-
颜色:
-
Light yellow to yellow
-
|
Elenbecestat(E2609)性质、用途与生产工艺
Elenbecestat (E2609)是一种新型的BACE1抑制剂,在单次给药后能长效地减低血浆中β-淀粉样蛋白的水平。
Elenbecestat(E2609)
上下游产品信息
上游原料
下游产品
更新日期 | 产品编号 | 产品名称 | CAS编号 | 包装 | 价格 |
---|
2024/04/30 | S8600 | Elenbecestat(E2609) Elenbecestat | 1388651-30-6 | 2mg | 1204.43元 |
2024/04/30 | S8600 | Elenbecestat(E2609) Elenbecestat | 1388651-30-6 | 5mg | 2432.44元 |
1388651-30-6, Elenbecestat(E2609) 相关搜索:
- 合成有机化合物配体
- 化合物ELENBECESTAT
- E2609 ; E-2609 ; E 2609 ; ELENBECESTAT
- 1388651-30-6
- N-(3-((4aS,5R,7aS)-2-amino-5-methyl-4a,5-dihydro-4H-furo[3,4-d][1,3]thiazin-7a(7H)-yl)-4-fluorophenyl)-5-(difluoromethyl)pyrazine-2-carboxamide
- 2-Pyrazinecarboxamide, N-[3-[(4aS,5R,7aS)-2-amino-5,7-dihydro-5-methyl-4H-furo[3,4-d][1,3]thiazin-7a(4aH)-yl]-4-fluorophenyl]-5-(difluoromethyl)-
- Alzheimer's disease,inhibit,Beta-secretase,E-2609,Inhibitor,Elenbecestat,E 2609,β-Secretase,BACE-1,BACE
- Elenbecestat(E26090
- Elenbecestat(E2609)